专利信息

首页 1 2 3 4 5 下页尾页共 41 条记录, 当前第1/5页。

专利标题：Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections

专利权人：Gilead Sciences, Inc.;

A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by Escherichia coli Klebsiella pneumoniae Klebsiella oxytoca Pseudomonas aeruginosa Haemophilus influenzae Proteus mirabilis Enterobacter species Serratia marcescens as well as those caused by Burkholderia cepacia Stenotrophomonas maltophilia Alcaligenes xylosoxidans and multidrug resistant Pseudomonas aeruginosa using a concentrated formulation o...

专利标题：Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections

专利权人：Gilead Sciences, Inc.;

±-Aztreonam lysinate is able to be administered via inhalation. It is useful in the treatment of pulmonary bacterial infections particularly gram-negative bacterial infections.

专利标题：Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections

专利权人：Gilead Sciences, Inc.;

±-Aztreonam lysinate is able to be administered via inhalation. It is useful in the treatment of pulmonary bacterial infections particularly gram-negative bacterial infections.

专利标题：Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections

专利权人：Gilead Sciences, Inc.;

Aztreonam lysinate is able to be administered via inhalation. It is useful in the treatment of pulmonary bacterial infections particularly gram-negative bacterial infections. Preparation of aztreonam lysinate using ��-aztreonam provides an advantageous manufacturing process and a product which has high purity and stability.

专利权人：Gilead Sciences, Inc.;

±-Aztreonam lysinate is able to be administered via inhalation. It is useful in the treatment of pulmonary bacterial infections particularly gram-negative bacterial infections.

专利标题：Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections

专利权人：Gilead Sciences, Inc.;

专利标题：Inhalerbar aztreonam uden arginin til behandling og forebyggelse af bakterielle lungeinfektioner

专利权人：Gilead Sciences, Inc.;

专利标题：Inhalable aztreonam without arginine for treatment and prevention of pulmonary bacterial infections

专利权人：Gilead Sciences, Inc.;

专利标题：Aztreonam inhalable sin arginina para tratamiento y prevención de infecciones bacterianas pulmonares

专利权人：Gilead Sciences, Inc.;

专利标题：Inhalable aztreonam without arginine for treatment and prevention of pulmonary bacterial infections

专利权人：Gilead Sciences, Inc.;

当前查询条件: [专利权人] 包含 'Gilead Sciences, Inc.' AND [药品] 包含 'Aztreonam'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. US20140037735A1	2014/2/6	US14/046539	2013/10/4
专利标题：Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections 专利权人：Gilead Sciences, Inc.; A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by Escherichia coli Klebsiella pneumoniae Klebsiella oxytoca Pseudomonas aeruginosa Haemophilus influenzae Proteus mirabilis Enterobacter species Serratia marcescens as well as those caused by Burkholderia cepacia Stenotrophomonas maltophilia Alcaligenes xylosoxidans and multidrug resistant Pseudomonas aeruginosa using a concentrated formulation o...

2. SI1641436T1	2013/12/31	SI20040032105T	2004/7/1
专利标题：Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections 专利权人：Gilead Sciences, Inc.; ±-Aztreonam lysinate is able to be administered via inhalation. It is useful in the treatment of pulmonary bacterial infections particularly gram-negative bacterial infections.

3. PT1641436E	2013/11/7	PT20040777564T	2004/7/1
专利标题：Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections 专利权人：Gilead Sciences, Inc.; ±-Aztreonam lysinate is able to be administered via inhalation. It is useful in the treatment of pulmonary bacterial infections particularly gram-negative bacterial infections.

4. EP2452672A3	2013/11/6	EP20120154996	2004/7/1
专利标题：Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections 专利权人：Gilead Sciences, Inc.; Aztreonam lysinate is able to be administered via inhalation. It is useful in the treatment of pulmonary bacterial infections particularly gram-negative bacterial infections. Preparation of aztreonam lysinate using ��-aztreonam provides an advantageous manufacturing process and a product which has high purity and stability.

5. ES2428030T3	2013/11/5	ES20040777564T	2004/7/1
专利标题：专利权人：Gilead Sciences, Inc.; ±-Aztreonam lysinate is able to be administered via inhalation. It is useful in the treatment of pulmonary bacterial infections particularly gram-negative bacterial infections.

6. EP1641436B1	2013/9/4	EP20040777564	2004/7/1
专利标题：Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections 专利权人：Gilead Sciences, Inc.;

7. DK2301524T3	2013/7/15	DK20100010411T	2001/12/20
专利标题：Inhalerbar aztreonam uden arginin til behandling og forebyggelse af bakterielle lungeinfektioner 专利权人：Gilead Sciences, Inc.;

8. PT2301524E	2013/7/10	PT20100010411T	2001/12/20
专利标题：Inhalable aztreonam without arginine for treatment and prevention of pulmonary bacterial infections 专利权人：Gilead Sciences, Inc.; A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by Escherichia coli Klebsiella pneumoniae Klebsiella oxytoca Pseudomonas aeruginosa Haemophilus influenzae Proteus mirabilis Enterobacter species Serratia marcescens as well as those caused by Burkholderia cepacia Stenotrophomonas maltophilia Alcaligenes xylosoxidans and multidrug resistant Pseudomonas aeruginosa using a concentrated formu...

9. ES2406405T3	2013/6/6	ES20100010411T	2001/12/20
专利标题：Aztreonam inhalable sin arginina para tratamiento y prevención de infecciones bacterianas pulmonares 专利权人：Gilead Sciences, Inc.; A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by Escherichia coli Klebsiella pneumoniae Klebsiella oxytoca Pseudomonas aeruginosa Haemophilus influenzae Proteus mirabilis Enterobacter species Serratia marcescens as well as those caused by Burkholderia cepacia Stenotrophomonas maltophilia Alcaligenes xylosoxidans and multidrug resistant Pseudomonas aeruginosa using a concentrated formu...

10. EP2301524B1	2013/4/24	EP20100010411	2001/12/20
专利标题：Inhalable aztreonam without arginine for treatment and prevention of pulmonary bacterial infections 专利权人：Gilead Sciences, Inc.; A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by Escherichia coli Klebsiella pneumoniae Klebsiella oxytoca Pseudomonas aeruginosa Haemophilus influenzae Proteus mirabilis Enterobacter species Serratia marcescens as well as those caused by Burkholderia cepacia Stenotrophomonas maltophilia Alcaligenes xylosoxidans and multidrug resistant Pseudomonas aeruginosa using a concentrated formu...

下载范围

下载内容